Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketek 5-day versus Augmentin 10-day for acute bacterial sinusitis
2004-001460-42Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Acute bacterial rhinosinusitis (ABRS) comparing Ketek with Augmentin (2 arms). Primary endpoint: Clinical efficacy at test of cure. Started Sep 2004; status: completed.
02
Drugs
telithromycinamoxicillin + clavulanate
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on 2004-001460-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001460-42.